Positive Top Line Safety and Efficacy Data from Phase 2 COVID-19 Study of Opaganib Posted bylwm100 January 4, 2021 Leave a comment on Positive Top Line Safety and Efficacy Data from Phase 2 COVID-19 Study of Opaganib https://www.redhillbio.com/RedHill/Templates/showpage.asp?DBID=1&LNGID=1&TMID=178&FID=2432&PID=0&IID=19319
